Ticker: CRL

Charles River Laboratories International, Inc. (NYSE: CRL) has recently reported its financial results for the quarterly period ended June 28, 2025. The company operates in the global drug development sector, providing essential services to pharmaceutical and biotechnology companies. Key Highligh...